Guangdong Raynovent Biotech Co., Ltd clinical trials

A subsidiary of Guangdong Zhongsheng Pharmaceutical Co., Ltd.

The registry lists 36 studies whose lead sponsor is Guangdong Raynovent Biotech Co., Ltd. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 36 of 36. All Guangdong Zhongsheng Pharmaceutical Co., Ltd. studies →

• Evaluation of the Bioequivalence of RAY1225 Injection in Healthy ParticipantsNot yet recruitingNCT07827027Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• A Mass Balance Study Of 14C-RAY1225 Injection In Healthy Chinese ParticipantsNot yet recruitingNCT07460284Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneNot yet recruitingNCT07139535Phase 3

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 DiabetesNot yet recruitingNCT07139548Phase 3

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are OverweightRecruitingNCT06893016Phase 3

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• A Study of RAY1225 in Participants With Impaired Liver FunctionRecruitingNCT06577415Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• A Study of RAY1225 in Participants With ObesityRecruitingNCT06254261Phase 2

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• The Safety, Tolerability and Pharmacokinetic Study of RAY1225CompletedNCT05835752Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and DigoxinActive, not recruitingNCT07362030Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza AActive, not recruitingNCT07229807Phase 3

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza AActive, not recruitingNCT07229820Phase 3

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Pharmacokinetics，Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza ACompletedNCT06656026Phase 2

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• A Study of RAY1225 in Participants With Type 2 DiabetesActive, not recruitingNCT06254274Phase 2

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Mass Balance Study of [14C]ZSP1273 in Healthy Adult Male Subjects in ChinaCompletedNCT05873426Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Pharmacokinetics of ZSP1273 in Participants With Severe Kidney DiseaseCompletedNCT06248567Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)Active, not recruitingNCT05692492Phase 2

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF）CompletedNCT05119972Phase 1/2

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• A Study of RAY1225 at Different Injection Sites in Participants With Different Body SizesCompletedNCT06577428Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• A Study of RAY1225 in Participants With Impaired Kidney FunctionCompletedNCT06613763Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Mass Balance Study of [14C]RAY1216 in Healthy Adult Male Subjects in ChinaCompletedNCT06362460Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Pharmacokinetics of Leritrelvir(Ray1216) in Elder ParticipantsCompletedNCT06169085Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and RifampinCompletedNCT06031454Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Severe Kidney DiseaseCompletedNCT06160622Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273CompletedNCT06164431Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Drug-durg Interaction of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and ProbenecidCompletedNCT05954624Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Hepatic ImpairmentCompletedNCT06161259Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and MidazolamCompletedNCT05942365Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Pharmacokinetics of ZSP1273 in Elder ParticipantsCompletedNCT06157450Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Pharmacokinetics of ZSP1273 in Participants With Hepatic ImpairmentCompletedNCT05856513Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza ACompletedNCT04683406Phase 3

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19CompletedNCT05620160Phase 3

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult ParticipantsCompletedNCT05829551Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and OseltamivirCompletedNCT05108051Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH)CompletedNCT04140123Phase 1/2

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP0678, and the Effect of Food on ZSP0678 PharmacokineticsCompletedNCT04137055Phase 1

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd

• Study of ZSP1273 in Patients With Acute Uncomplicated Influenza ACompletedNCT04024137Phase 2

  Sponsor listed in the registry: Guangdong Raynovent Biotech Co., Ltd